Financials data is unavailable for this security.
View more
Year on year Sanofi SA 's net income fell -35.49% from 8.37bn to 5.40bn despite relatively flat revenues. A contributing factor has been an increase in the percentage of sales devoted to the cost of goods sold from 30.17% to 30.65%.
Gross margin | 68.91% |
---|---|
Net profit margin | 9.11% |
Operating margin | 13.92% |
Return on assets | 3.39% |
---|---|
Return on equity | 5.80% |
Return on investment | 4.33% |
More ▼
Cash flow in EURView more
In 2023, cash reserves at Sanofi SA fell by 4.03bn. However, the company earned 10.26bn from its operations for a Cash Flow Margin of 22.09%. In addition the company used 6.20bn on investing activities and also paid 8.05bn in financing cash flows.
Cash flow per share | 5.20 |
---|---|
Price/Cash flow per share | 20.04 |
Book value per share | 58.10 |
---|---|
Tangible book value per share | -3.23 |
More ▼
Balance sheet in EURView more
Current ratio | 1.00 |
---|---|
Quick ratio | 0.6484 |
Total debt/total equity | 0.3266 |
---|---|
Total debt/total capital | 0.2454 |
More ▼
Growth rates in EUR
SmartText is unavailable
Div yield(5 year avg) | 3.89% |
---|---|
Div growth rate (5 year) | 4.14% |
Payout ratio (TTM) | 111.60% |
EPS growth(5 years) | 4.55 |
---|---|
EPS (TTM) vs TTM 1 year ago | -50.94 |
More ▼